Dr. Reddy's Laboratories Ltd (RDY) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Dr. Reddy's Laboratories Ltd (RDY) over the last 10 years. The current PE ratio for Dr. Reddy's Laboratories Ltd as of November 20, 2017 is 34.25.
|Medical||Medical - Generic Drugs||$5.850B||$2.171B|
|Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection|